BioMarin Pharmaceutical
BMRN
#1885
Rank
$10.86 B
Marketcap
$56.54
Share price
-0.79%
Change (1 day)
-10.76%
Change (1 year)

BioMarin Pharmaceutical (BMRN) Fails to deliver data

Key failure to deliver metrics for BioMarin Pharmaceutical:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioMarin Pharmaceutical (BMRN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioMarin Pharmaceutical (BMRN) - since 2013

Volume in USD (price x number of shares), data since 2013

BioMarin Pharmaceutical (BMRN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$0.55 M-95.75%
2025$13.12 M-48.09%
2024$25.28 M-2.78%
2023$26 M-3.87%
2022$27.05 M-24.36%
2021$35.76 M-61.48%
2020$92.85 M217.25%
2019$29.26 M-60.68%
2018$74.43 M66.59%
2017$44.68 M-18.44%
2016$54.78 M-33.54%
2015$82.43 M51.23%
2014$54.5 M57.97%
2013$34.5 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sanofi
SNY
$10.89 M$69.64 M๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
$3.69 M$9.48 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$0.39 M$8.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$4.76 M$11 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$8.6 M$17.99 M๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
$0.27 M$1.01 M๐Ÿ‡บ๐Ÿ‡ธ USA